| 000 | 01852 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514060048.0 | ||
| 264 | 0 | _c20030306 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a0030-3755 | ||
| 024 | 7 |
_a10.1159/000067548 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRouland, Jean-François | |
| 245 | 0 | 0 |
_aTimolol 0.1% gel (Nyogel 0.1% once daily versus conventional timolol 0.5% solution twice daily: a comparison of efficacy and safety. _h[electronic resource] |
| 260 |
_bOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde _c |
||
| 300 |
_a449-54 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGels |
| 650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTimolol _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVisual Acuity _xdrug effects |
| 700 | 1 | _aMorel-Mandrino, Patricia | |
| 700 | 1 | _aElena, Pierre-Paul | |
| 700 | 1 | _aPolzer, Heinz | |
| 700 | 1 | _aSunder Raj, Palaniswamy | |
| 773 | 0 |
_tOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde _gvol. 216 _gno. 6 _gp. 449-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000067548 _zAvailable from publisher's website |
| 999 |
_c12365184 _d12365184 |
||